Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report) shares dropped 4.3% during mid-day trading on Tuesday . The company traded as low as $7.13 and last traded at $7.20. Approximately 7,849 shares changed hands during mid-day trading, an increase of 9% from the average daily volume of 7,218 shares. The stock had previously closed at $7.52.
Talis Biomedical Stock Performance
The company has a 50-day simple moving average of $7.92 and a 200 day simple moving average of $6.83. The company has a market capitalization of $13.10 million, a P/E ratio of -0.17 and a beta of 1.69.
Talis Biomedical (NASDAQ:TLIS – Get Free Report) last issued its quarterly earnings results on Tuesday, November 14th. The company reported ($8.62) EPS for the quarter. The business had revenue of $0.14 million during the quarter. Talis Biomedical had a negative return on equity of 72.82% and a negative net margin of 3,436.98%.
Institutional Trading of Talis Biomedical
About Talis Biomedical
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also develops Talis One tests for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B.
- Five stocks we like better than Talis Biomedical
- How to Buy Metaverse Stock Step by Step
- Is the dip in Atlassian stock a sneaky buy opportunity?
- How to Calculate Return on Investment (ROI)
- Caterpillar stock hits new highs; time to ring the register?
- When to Sell a Stock for Profit or Loss
- 5 medical stocks growing earnings by triple digits
Receive News & Ratings for Talis Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talis Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.